Skip to content
★ Sign in to follow
KA

Kajsa Anna Margareta Larsson

Cinclus Pharma Holding AB (publ)
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€40k
▼ Sales (0 ops.)
—

Latest filing published 05 Jun 2026 for Cinclus Pharma Holding AB (publ), €14k.

Filing timeline

BuySale
Kajsa Anna Margareta Larsson

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
33%
Median T+90
-15.7%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Kajsa Anna Margareta Larsson: trading record in brief

Kajsa Anna Margareta Larsson is a declared insider of Cinclus Pharma Holding AB (publ), with filings sourced from Finansinspektionen. Over a trading history stretching from 20 June 2024 to 4 June 2026, the count stands at 4 filings.

Every open-market trade on record is a purchase: 4 purchases worth €40k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 2 purchases and no sales.

The median purchase comes to €11k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -15.7%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 5 June 2026 with an open-market purchase (€14k) in Cinclus Pharma Holding AB (publ). Filings reach the Finansinspektionen feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Kajsa Anna Margareta Larsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesCinclus Pharma Holding AB (publ)
    157,300 SEK30FI-SE
    13,000 shares@ SEK 12.10100.0% of flowAktieISIN SE0020388577FI:A003Z626-1
    Canonical exit: 2 Sept 2026 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesCinclus Pharma Holding AB (publ)
    82,740 SEK25FI-SE
    1,970 shares@ SEK 42.0028.2% of flowAktieISIN SE0020388577FI:csv-3b7aad21075de5942074
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesCinclus Pharma Holding AB (publ)
    48,712 SEK24FI-SE
    1,355 shares@ SEK 35.9516.6% of flowAktieISIN SE0020388577FI:csv-a31fcab77ae3ab213578
    Canonical exit: 18 Sept 2024 (T+90)

3 of 3 declarations